Načítá se...
Therapy to target renal cell carcinoma using (131)I-labeled B7-H3 monoclonal antibody
B7-H3 is a tumor-associated antigen that plays a critical role in potential tumor-targeted therapy. In this study, we aimed to assess the radiobiological effect of (131)I-labeled B7-H3 monoclonal antibody ((131)I-4H7) in nude mice with human renal cell carcinoma (RCC) and evaluate the effect of (131...
Uloženo v:
| Vydáno v: | Oncotarget |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals LLC
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029751/ https://ncbi.nlm.nih.gov/pubmed/27058890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8550 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|